191 related articles for article (PubMed ID: 31176094)
1. Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
Maslov DA; Korotina AV; Shur KV; Vatlin AA; Bekker OB; Tolshchina SG; Ishmetova RI; Ignatenko NK; Rusinov GL; Charushin VN; Danilenko VN
Eur J Med Chem; 2019 Sep; 178():39-47. PubMed ID: 31176094
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
3. Novel imidazo[2,1-b][1,3,4]thiadiazole carrying rhodanine-3-acetic acid as potential antitubercular agents.
Alegaon SG; Alagawadi KR; Sonkusare PV; Chaudhary SM; Dadwe DH; Shah AS
Bioorg Med Chem Lett; 2012 Mar; 22(5):1917-21. PubMed ID: 22325950
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and evaluation of benzodiazaborine compounds against M. tuberculosis H37Rv in vitro.
Davis MC; Franzblau SG; Martin AR
Bioorg Med Chem Lett; 1998 Apr; 8(7):843-6. PubMed ID: 9871552
[TBL] [Abstract][Full Text] [Related]
5. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
6. Anti-Mycobacterium tuberculosis activity of naphthoimidazoles combined with isoniazid and rifampicin.
Corrêa Barros LP; Del Rio KP; Carvalho TDSC; Pinto MDCFR; de Moura KCG; Halicki PCB; Ramos DF; da Silva PEA
Tuberculosis (Edinb); 2018 Jul; 111():198-201. PubMed ID: 30029908
[TBL] [Abstract][Full Text] [Related]
7. Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.
Guillemont J; Meyer C; Poncelet A; Bourdrez X; Andries K
Future Med Chem; 2011 Sep; 3(11):1345-60. PubMed ID: 21879841
[TBL] [Abstract][Full Text] [Related]
8. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
9. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
Wang A; Lv K; Li L; Liu H; Tao Z; Wang B; Liu M; Ma C; Ma X; Han B; Wang A; Lu Y
Eur J Med Chem; 2019 Sep; 178():715-725. PubMed ID: 31229874
[TBL] [Abstract][Full Text] [Related]
11. Secondary metabolites from Tetracera potatoria stem bark with anti-mycobacterial activity.
Fomogne-Fodjo MC; Ndinteh DT; Olivier DK; Kempgens P; van Vuuren S; Krause RW
J Ethnopharmacol; 2017 Jan; 195():238-245. PubMed ID: 27864111
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
[TBL] [Abstract][Full Text] [Related]
15. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
[TBL] [Abstract][Full Text] [Related]
16. An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis.
Mori M; Sammartino JC; Costantino L; Gelain A; Meneghetti F; Villa S; Chiarelli LR
Curr Top Med Chem; 2019; 19(9):646-661. PubMed ID: 30827246
[TBL] [Abstract][Full Text] [Related]
17. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
[TBL] [Abstract][Full Text] [Related]
18. Ring-substituted imidazoles as a new class of anti-tuberculosis agents.
Gupta P; Hameed S; Jain R
Eur J Med Chem; 2004 Sep; 39(9):805-14. PubMed ID: 15337293
[TBL] [Abstract][Full Text] [Related]
19. Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy.
Pieroni M; Machado D; Azzali E; Santos Costa S; Couto I; Costantino G; Viveiros M
J Med Chem; 2015 Aug; 58(15):5842-53. PubMed ID: 26197353
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]